How estrogen affects the brain's control of blood sugar and memory
Impact of estradiol on the central regulation of glucose homeostasis and subsequent implications for hippocampal function.
This project looks at whether restoring estrogen in midlife can help the brain keep blood sugar steady and protect memory for people with obesity or type 2 diabetes.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11269233 on NIH RePORTER |
What this research studies
Researchers will study how loss of estrogen after menopause changes hypothalamic brain circuits that control liver glucose production and overall blood sugar balance. They will test whether giving estradiol in midlife restores those circuits and improves hippocampal synaptic function linked to memory, using laboratory models and molecular studies tied to human disease. The team will connect changes in autonomic regulation and glucose homeostasis to the kinds of cognitive problems seen in Alzheimer’s and related dementias. Findings will be compared to observations from patients with obesity, insulin resistance, or dementia risk factors to guide future human therapies.
Who could benefit from this research
Good fit: Ideal candidates would be midlife or postmenopausal women, especially those with obesity or type 2 diabetes who are concerned about memory or dementia risk.
Not a fit: People who are premenopausal, men, or whose memory problems are unrelated to metabolic or hormone changes may be unlikely to benefit directly from this work.
Why it matters
Potential benefit: If successful, this work could point to hormone-based or related treatments to improve blood sugar control and reduce memory decline after menopause.
How similar studies have performed: Animal studies and some timing-focused human hormone trials show promise that midlife estrogen can help memory and metabolism, but clinical results have been mixed and mechanisms remain under study.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Zsombok, Andrea — Tulane University of Louisiana
- Study coordinator: Zsombok, Andrea
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.